{"id":"W2891197019","doi":"10.1200/jco.2017.35.15_suppl.6600","title":"Are surrogate endpoints unbiased metrics compared to hazard ratio for death? An evaluation of clinical benefit scores (CBS) in the American Society of Clinical Oncology (ASCO) value framework.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; University of Calgary; Ottawa Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Surrogate endpoint; Hazard ratio; Internal medicine; Clinical endpoint; Clinical Oncology; Oncology; Clinical trial; Progression-free survival; Randomized controlled trial; Confidence interval; Cancer; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2476905,0.001098266,0.001956462,0.006324668,0.0006048984,0.003278006,0.0009999294,0.001020077,0.001441591],"category_scores_gemma":[0.4730031,0.0003959173,0.002544661,0.005510108,0.003195614,0.002648459,0.003622759,0.001612479,0.0001663781],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003961476,"about_ca_system_score_gemma":0.002996941,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001940871,"about_ca_topic_score_gemma":0.002102498,"domain_scores_codex":[0.765807,0.1897961,0.009907682,0.004838071,0.02866026,0.0009910102],"domain_scores_gemma":[0.4657546,0.4680376,0.03704901,0.009333674,0.01808636,0.001738696],"domain_codex":null,"domain_gemma":"evaluation","domain_candidate":"evaluation","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01099036,0.000402198,0.3831087,0.004470454,0.01114099,0.0002616689,0.003410664,0.05451071,0.001322964,0.07700081,0.01018,0.4432004],"study_design_scores_gemma":[0.002339551,0.0124897,0.3527004,0.004392163,0.004752817,0.001139448,0.00285232,0.3819976,0.003963369,0.2014174,0.03137766,0.0005775194],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5347751,0.04103281,0.391129,0.004967435,0.0005355385,0.004187954,0.003967372,0.000274301,0.01913038],"genre_scores_gemma":[0.928133,0.0007847176,0.06864422,0.0004202863,0.00008406952,0.001161061,0.0005631362,0.00002827165,0.0001812352],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7523094,"threshold_uncertainty_score":0.9277315,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.8654856141165033,"score_gpt":0.6718629996983625,"score_spread":0.1936226144181408,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}